Felix Baker
Director at Kymera Therapeutics, Inc. (KYMR); 10% Owner at Entrada Therapeutics, Inc. (TRDA)
Purchase track record
Market-like. Based on 2 purchases with a full 90 days of price history.
55
Avg. 90-day return+3.5%
vs. S&P 500+3.1%
Beat the market50%
Paper profit on buys+$52.9M
Total bought / sold$173M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Dec 11SEC | KYMRKymera Therapeutics, Inc. | Buy | 167,192701,326 held (+31%) | $86.00 | $14.4M | +30.7% |
| Dec 11SEC | KYMRKymera Therapeutics, Inc. | Buy | 1,838,6217,955,916 held (+30%) | $86.00 | $158M | +30.7% |
| Nov 24SEC | TRDAEntrada Therapeutics, Inc. | Buy | 1,213380,152 held (+0%) | $9.07 | $11K | -37.5% |
| Nov 24SEC | TRDAEntrada Therapeutics, Inc. | Buy | 13,3864,678,310 held (+0%) | $9.07 | $121K | -37.5% |
| Nov 24SEC | TRDAEntrada Therapeutics, Inc. | Buy | 1,186381,338 held (+0%) | $9.07 | $11K | -37.5% |
| Nov 24SEC | TRDAEntrada Therapeutics, Inc. | Buy | 13,0824,691,392 held (+0%) | $9.07 | $119K | -37.5% |
- Buy
Director Felix Baker bought $14.4M of KYMR at $86.00 — first open-market purchase in our records; raises the stake by 31%.
- Buy
Director Felix Baker bought $158M of KYMR at $86.00 — largest purchase by this insider in our records; raises the stake by 30%.
- Buy
10% Owner Felix Baker bought $11K of TRDA at $9.07 — first open-market purchase in our records.
- Buy
10% Owner Felix Baker bought $121K of TRDA at $9.07 — largest purchase by this insider in our records.